2nd Quarter - Report

EMD MILLIPORE CORPORATION for EMD MILLIPORE CORPORATION

Period 2nd Quarter 2026 Filed Jul 20, 2026 Signed by James W, Carson, Attorney & Agent for Filer

Official filing
Firm
EMD MILLIPORE CORPORATION
Client
EMD MILLIPORE CORPORATION
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Tariff (miscellaneous tariff bills) TAR

Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Manufacturing MAN

General discussions related to federal procurement policy

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.